-
In light of a recent Government Accounting Office report that found that the Joint Commission on Accreditation of Healthcare Organizations failed to detect deficiencies in the Medicare Conditions of Participation (COPs) during surveys, quality managers need to take extra care to ensure their organizations are compliant with, says Patrice L. Spath, BA, RHIT, a health care quality specialist with Brown-Spath & Associates in Forest Grove, OR.
-
According to recent data from the Joint Com-mission on Accreditation of Healthcare Organizations, compliance with the National Patient Safety Goals (NPSGs) is more than 94%, with one notable exception: the requirement to standardize abbreviations, which falls to 85% compliance.
-
-
This article focuses on specific populations presenting with abdominal pain to the ED and their specific or unique diagnoses. The pediatric, elderly, pregnant, and immunocompromised patients are special populations that pose a particular challenge to clinicians. These high-risk groups often present atypically, and serious conditions can be missed or misdiagnosed. This article discusses unusual diagnoses that often present with abdominal pain as one of the main symptoms.
-
-
The FDA has granted clearance to a product that may shock some consumers literally. Philips Medical Systems (Bothell, Washington) got the nod from the FDA in mid-September to market its HeartStart Home Defibrillator over the counter for the treatment of sudden cardiac arrest (SCA), the first such clearance in the U.S.
-
GE Healthcare (Waukesha, Wisconsin) has unveiled what it touted as the visual stethoscope of the future, a new, miniaturized cardiovascular ultrasound system it said was so small and lightweight that it will transform the way doctors see and treat heart disease.
-
Several sessions held during last months congress of the European Society of Cardiology (ESC; Sophia Antipolis, France) in Munich, Germany, focused on the diabetic state of patients with coronary artery disease.
-
Congestive heart failure (CHF) is a major and growing worldwide public health problem that is creating demands for a wide range of diagnostic, therapeutic and patient-monitoring technologies in Europe and most other developed regions.
-
Guidant (Indianapolis) said that the FDA has approved an expanded indication for the companys portfolio of cardiac resynchronization therapy defibrillators (CRT-D).
